Education
About Us
Working with TipRanks
Follow Us
Electrocore Llc (ECOR)
NASDAQ:ECOR
ECOR Stock Chart & Stats
$4.60
$0.45(2.64%)
At close: 4:00 PM EST
$4.60
$0.45(2.64%)
Day’s Range― - ―
52-Week Range$4.16 - $19.49
Previous CloseN/A
Volume24.66K
Average Volume (3M)43.65K
Market Cap
$36.78M
Enterprise Value$39.41M
Total Cash (Recent Filing)$13.20M
Total Debt (Recent Filing)$10.81M
Price to Earnings (P/E)―
Beta1.66
Next Earnings
Mar 05, 2026EPS Estimate
-0.39Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.40
Shares Outstanding7,995,903
10 Day Avg. Volume46,574
30 Day Avg. Volume43,649
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)16.08
Price to Sales (P/S)4.82
P/FCF Ratio-17.46
Enterprise Value/Market Cap1.07
Enterprise Value/Revenue1.32
Enterprise Value/Gross Profit1.54
Enterprise Value/Ebitda-3.11
Forecast
1Y Price Target
$18.50Price Target Upside302.17% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-1.66
Revenue Forecast (FY)$30.78M
Bulls Say, Bears Say
Bulls Say
Market ExpansionThe VA/DoD prescribing facility count increased significantly, showing expansion in a key market channel.
Product PerformanceThe Quell product exceeded expectations, and its integration into the VA network is anticipated to significantly boost revenue.
Revenue GuidanceElectrocore raised its 2025 revenue guidance, indicating strong performance and growth expectations.
Bears Say
Profitability DelayDelayed profitability is expected due to higher anticipated operating expenses, justifying a discounted valuation.
Electrocore News
ECOR FAQ
What was Electrocore Llc’s price range in the past 12 months?
Electrocore Llc lowest stock price was $4.16 and its highest was $19.49 in the past 12 months.
What is Electrocore Llc’s market cap?
Electrocore Llc’s market cap is $36.78M.
When is Electrocore Llc’s upcoming earnings report date?
Electrocore Llc’s upcoming earnings report date is Mar 05, 2026 which is in 73 days.
How were Electrocore Llc’s earnings last quarter?
Electrocore Llc released its earnings results on Nov 05, 2025. The company reported -$0.4 earnings per share for the quarter, the consensus estimate of -$0.4 by $0.
Is Electrocore Llc overvalued?
According to Wall Street analysts Electrocore Llc’s price is currently Undervalued.
Does Electrocore Llc pay dividends?
Electrocore Llc does not currently pay dividends.
What is Electrocore Llc’s EPS estimate?
Electrocore Llc’s EPS estimate is -0.39.
How many shares outstanding does Electrocore Llc have?
Electrocore Llc has 7,995,903 shares outstanding.
What happened to Electrocore Llc’s price movement after its last earnings report?
Electrocore Llc reported an EPS of -$0.4 in its last earnings report, expectations of -$0.4. Following the earnings report the stock price went up 23.207%.
Which hedge fund is a major shareholder of Electrocore Llc?
Currently, no hedge funds are holding shares in ECOR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Electrocore Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$18.50 (302.17% Upside)
$18.50 (302.17% Upside)
Blogger Sentiment
Bullish
ECOR Sentiment 100%
Sector Average 68%
Sector Average 68%
Insider Transactions
Sold Shares
Worth $21.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 0.3%
Last 30 Days ▼ 0.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-68.31%
12-Months-Change
Fundamentals
Return on Equity
-337.84%
Trailing 12-Months
Asset Growth
1.74%
Trailing 12-Months
Company Description
Electrocore Llc
Electrocore, Inc. is a medical technology company focused on non-invasive neurostimulation therapies. It specializes in developing devices for the treatment of various neurological and psychiatric conditions, with its flagship product being the gammaCore device, which is used for the acute and preventive treatment of cluster headaches and migraines. The company operates primarily in the healthcare sector, leveraging advanced technology to provide effective solutions for pain management and chronic conditions.
ECOR Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and successful strategic initiatives such as the NeuroMetrix acquisition and expansion in the VA system. However, these were balanced by increased net losses, delayed profitability, and ongoing legal challenges. Overall, the company is investing heavily in its future, which may pay off, but current financials are impacted.View all ECOR earnings summariesECOR Stock 12 Month Forecast
Average Price Target
$18.50
▲(302.17% Upside)
Technical Analysis
Myomo
―
Modular Medical
―
NeuroOne Medical Technologies
―
Vivos Therapeutics
―
Adagio Medical Holdings
―
Ownership Overview
20.82% Insiders
3.90% Mutual Funds
1.76% Other Institutional Investors
70.84% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---